Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 37, 2007, Pages 14694-14699

  Partanen, Johanna I ^a   Nieminen, Anni I ^a   Mäkelä, Tomi P ^a   Klefstrom, Juha ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

3D culture; Apoptosis

Indexed keywords

BIM PROTEIN; CELL PROTEIN; DEATH RECEPTOR; MYC PROTEIN; PROTEIN BID; PROTEIN KINASE LKB1; PROTEIN PAR4; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CYTOARCHITECTURE; EPITHELIUM CELL; GENE ACTIVATION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; ORGAN CULTURE TECHNIQUES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, DEATH DOMAIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 35548952703     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0704677104     Document Type: Article

References (27)

1. Debnath J, Brugge JS (2005) Nat Rev Cancer 5:675-688.
2. O'Brien LE, Zegers MM, Mostov KE (2002) Nat Rev Mol Cell Biol 3:531-537.
3. Bilder D (2004) Genes Dev 18:1909-1925.
4. Pagliarini RA, Xu T (2003) Science 302:1227-1231.
5. Schmeichel KL, Bissell MJ (2003) J Cell Sci 116:2377-2388.
6. Debnath J, Muthuswamy SK, Brugge JS (2003) Methods 30:256-268.
7. Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ (1989) Development (Cambridge, UK) 105:223-235.
8. Pelengaris S, Khan M, Evan G (2002) Nat Rev Cancer 2:764-776.
9. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS (2002) Cell 111:29-40.
10. Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, Bissell MJ (1987) Proc Natl Acad Sci USA 84:136-140.
11. Weaver VM, Lelievre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, Werb Z, Bissell MJ (2002) Cancer Cell 2:205-216.
12. Baas AF, Smit L, Clevers H (2004) Trends Cell Biol 14:312-319.
13. Baas AF, Kuipers J, van der Wel NN, Batlle E, Koerten HK, Peters PJ, Clevers HC (2004) Cell 116:457-466.
14. Zhang L, Li J, Young LH, Caplan MJ (2006) Proc Natl Acad Sci USA 103:17272-17277.
15. Zheng B, Cantley LC (2007) Proc Natl Acad Sci USA 104:819-822.
16. Forster LF, Defres S, Goudie DR, Baty DU, Carey FA (2000) J Clin Pathol 53:791-793.
17. Fenton H, Carlile B, Montgomery EA, Carraway H, Herman J, Sahin F, Su GH, Argani P (2006) Appl Immunohistochem Mol Morphol 14:146-153.
18. Katajisto P, Vallenius T, Vaahtomeri K, Ekman N, Udd L, Tiainen M, Makela TP (2007) Biochim Biophys Acta 1775:63-75.
19. Zhuang ZG, Di GH, Shen ZZ, Ding J, Shao ZM (2006) Mol Cancer Res 4:843-849.
20. Forcet C, Etienne-Manneville S, Gaude H, Fournier L, Debilly S, Salmi M, Baas A, Olschwang S, Clevers H, Billaud M (2005) Hum Mol Genet 14:1283-1292.
21. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, Cantley LC (2004) Cancer Cell 6:91-99.
22. Nieminen AI, Partanen JI, Hau A, Klefstrom J (2007) EMBO J 26:1055-1067.
23. Brumby AM, Richardson HE (2003) EMBO J 22:5769-5779.
24. Ylikorkala A, Rossi DJ, Korsisaari N, Luukko K, Alitalo K, Henkemeyer M, Makela TP (2001) Science 293:1323-1326.
25. Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, Fawcett JP, Pawson T, Muthuswamy SK (2006) Nat Cell Biol 8:1235-1245.
26. Boudreau N, Werb Z, Bissell MJ (1996) Proc Natl Acad Sci USA 93:3509-3513.
27. Egle A, Harris AW, Bouillet P, Cory S (2004) Proc Natl Acad Sci USA 101:6164-6169.